1. Responses of Human Colorectal Tumor Cells to Treatment with the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody ICR62 Used Alone and in Combination with the EGFR Tyrosine Kinase Inhibitor Gefitinib
   Matthew P. Cunningham et al, 2006, Cancer Research CrossRef
2. Evaluation of the Therapeutic Potential of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Gefitinib in Preclinical Models of Bladder Cancer
   Jose L. Dominguez-Escrig et al, 2004, Clinical Cancer Research CrossRef
3. A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)
   Edgar R. Wood et al, 2004, Cancer Research CrossRef
4. Interaction between epidermal growth factor receptor– and cyclooxygenase 2–mediated pathways and its implications for the chemoprevention of head and neck cancer
   Mi Sun Choe et al, 2005, Molecular Cancer Therapeutics CrossRef